272 related articles for article (PubMed ID: 34108939)
1. Epigenomics in Hurthle Cell Neoplasms: Filling in the Gaps Towards Clinical Application.
Canberk S; Lima AR; Pinto M; Soares P; Máximo V
Front Endocrinol (Lausanne); 2021; 12():674666. PubMed ID: 34108939
[TBL] [Abstract][Full Text] [Related]
2. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC
Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852
[TBL] [Abstract][Full Text] [Related]
3. Short Review: Genomic Alterations in Hürthle Cell Carcinoma.
Ganly I; McFadden DG
Thyroid; 2019 Apr; 29(4):471-479. PubMed ID: 30848171
[TBL] [Abstract][Full Text] [Related]
4. Molecular alterations in Hürthle cell neoplasms of thyroid: A fine needle aspiration cytology study with cytology-histology correlation.
Gilani SM; Ross JA; Prasad ML; Hammers L; Cai G; Adeniran AJ
Cancer Cytopathol; 2021 May; 129(5):363-373. PubMed ID: 33045146
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
[TBL] [Abstract][Full Text] [Related]
6. The biology and the genetics of Hurthle cell tumors of the thyroid.
Máximo V; Lima J; Prazeres H; Soares P; Sobrinho-Simões M
Endocr Relat Cancer; 2012 Aug; 19(4):R131-47. PubMed ID: 22514109
[TBL] [Abstract][Full Text] [Related]
7. Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer.
Marzese DM; Hoon DS
Expert Rev Mol Diagn; 2015 May; 15(5):647-64. PubMed ID: 25797072
[TBL] [Abstract][Full Text] [Related]
8. Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance.
Máximo V; Sobrinho-Simões M
Virchows Arch; 2000 Aug; 437(2):107-15. PubMed ID: 10993269
[TBL] [Abstract][Full Text] [Related]
9. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
Zhang P; Zhang M
Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic biomarkers in the blood of patients with urological malignancies.
Ellinger J; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer.
Roy D; Tiirikainen M
Trends Cancer; 2020 Feb; 6(2):78-81. PubMed ID: 32061307
[TBL] [Abstract][Full Text] [Related]
14. Methods for cancer epigenome analysis.
Nagarajan RP; Fouse SD; Bell RJ; Costello JF
Adv Exp Med Biol; 2013; 754():313-38. PubMed ID: 22956508
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
Covach A; Patel S; Hardin H; Lloyd RV
Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic epigenetic biomarkers in cancer.
Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
[TBL] [Abstract][Full Text] [Related]
17. Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.
Nogueira da Costa A; Herceg Z
Mol Oncol; 2012 Dec; 6(6):704-15. PubMed ID: 22925902
[TBL] [Abstract][Full Text] [Related]
18. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors.
Conti L; Vatrano S; Bertero L; Masu L; Pacchioni D; Daniele L; De Rosa G; Cassoni P; Volante M; Papotti M
Hum Pathol; 2017 Nov; 69():23-30. PubMed ID: 28962946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
